Opus Genetics, Inc.
IRD
DELAYED 1 MONTH
5 insider filings · Latest: Jul 23, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | Jul 27 8:08 PM | Benjamin R YerxaDirector, President | Sale | 7,429 | $2.97 | $22.1K | 704,106(D) | View → |
| Jul 23, 2026 | Jul 27 8:07 PM | Joseph K SchachleChief Operating Officer | Sale | 4,644 | $2.94 | $13.7K | 291,440(D) | View → |
| Jul 23, 2026 | Jul 27 8:07 PM | George MagrathDirector, Chief Executive Officer | Sale | 9,475 | $2.95 | $27.9K | 1,731,869(D) | View → |
| Jul 23, 2026 | Jul 27 8:06 PM | Robert E. GagnonChief Financial Officer | Sale | 7,783 | $2.95 | $22.9K | 584,375(D) | View → |
| May 18, 2026 | May 20 11:29 PM | Foundation Fighting Blindness Retinal Degeneration FundDirector, Other | Sale | 1,700,000 | $4.35 | $7.4M | 3,792,171(D) | View → |
Stock Options & Derivatives
No transactions found.